Exane Derivatives’s Royal Caribbean RCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$419 Sell
12
-42
-78% -$2.61K ﹤0.01% 592
2022
Q1
$4.52K Sell
54
-13
-19% -$1.02K ﹤0.01% 706
2021
Q4
$5.15K Sell
67
-404
-86% -$32.8K ﹤0.01% 617
2021
Q3
$41.9K Sell
471
-100
-18% -$8.09K 0.01% 634
2021
Q2
$44.8K Hold
571
0.01% 656
2021
Q1
$48.9K Sell
571
-2,573
-82% -$204K 0.01% 518
2020
Q4
$235K Buy
3,144
+221
+8% +$15.4K 0.07% 288
2020
Q3
$189K Buy
2,923
+2,782
+1,973% +$164K 0.05% 213
2020
Q2
$7.09K Sell
141
-3,720
-96% -$168K ﹤0.01% 431
2020
Q1
$124K Buy
3,861
+3,126
+425% +$286K 0.03% 255
2019
Q4
$97.5K Hold
735
0.02% 318
2019
Q3
$79.6K Hold
735
0.01% 337
2019
Q2
$89.1K Hold
735
0.02% 341
2019
Q1
$84.2K Buy
735
+338
+85% +$38.4K 0.02% 313
2018
Q4
$38.8K Buy
397
+386
+3,509% +$42.3K 0.01% 385
2018
Q3
$1.42K Sell
11
-14,223
-100% -$1.67M ﹤0.01% 516
2018
Q2
$1.47M Buy
14,234
+13,217
+1,300% +$1.45M 0.25% 90
2018
Q1
$118K Buy
1,017
+999
+5,550% +$126K 0.02% 281
2017
Q4
$2.15K Sell
18
-14,079
-100% -$1.74M ﹤0.01% 453
2017
Q3
$1.67M Sell
14,097
-3,635
-20% -$425K 0.31% 63
2017
Q2
$1.94M Sell
17,732
-8,951
-34% -$950K 0.42% 67
2017
Q1
$2.62M Buy
+26,683
New +$2.5M 0.59% 57
2016
Q1
Sell
-185,906
Closed -$18.8M 609
2015
Q4
$18.8M Sell
185,906
-18,978
-9% -$1.81M 2.58% 5
2015
Q3
$18.3M Buy
204,884
+204,699
+110,648% +$18M 2.31% 14
2015
Q2
$14.6K Buy
+185
New +$14.1K ﹤0.01% 351

Other funds holding RCL

Exane Derivatives's RCL Position: Q2 2022 in Review

Exane Derivatives reduced its Royal Caribbean (RCL) stake by 78% in Q2 2022, selling an estimated $2.61K and leaving 12 shares worth $419. The position accounts for ﹤0.01% of the portfolio, ranked #592.

Exane Derivatives first reported a position in RCL in Q2 2015 and has held it in 25 quarters since. The position peaked at $18.8M in Q4 2015. 569 funds tracked by Wall St. Rank hold RCL as of Q2 2022.

  • Exane Derivatives held 12 shares of Royal Caribbean worth $419 as of Q2 2022.
  • Exane Derivatives sold 42 Royal Caribbean shares in Q2 2022, an estimated $2.61K.
  • Royal Caribbean made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #592 holding.
  • Exane Derivatives first reported a position in Royal Caribbean in Q2 2015 and has held it in 25 quarters since.
  • Exane Derivatives's Royal Caribbean position peaked at $18.8M in Q4 2015.
  • 569 funds tracked by Wall St. Rank held Royal Caribbean as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.